The nationwide experiment will initially include around 100,000 volunteers.
Researchers develop a new technique to selectively activate neurons deep in the rodent brain, taking a step toward noninvasive brain stimulation for neurological disorders.
The Scientist
Most Recent
Experimental Drug Relieves Blast-Related PTSD in a Rat Model of Traumatic Brain Injury
| February 2, 2018
The compound, BCI-838, is already in human clinical trials as a possible treatment for depression.
The test uses levels of plasma amyloid-β to estimate the buildup of protein plaques in the brain.
Meet some of the people featured in the February 2018 issue of The Scientist.
Researchers are using souped-up mass spectrometry to localize proteins within brain cells.
New technology could open doors for researchers studying animals’ most complex organ.
Take a break from the bench to puzzle and peruse.
Studies in mice suggest that other flaviviruses, such as West Nile virus and Powassan virus, may cause birth defects, too.
After years of obscurity, strains of mice with mutations in particular genes are thrust to the fore of autism research.
In chapter 1, “The Bad Language Brain: Neuroscience and Swearing,” author Emma Byrne sets the scene for her book by telling the story of the hapless and potty-mouthed Phineas Gage.
Popular Now
-
The Nutshell Estonia Offers Free Genetic Testing to Residents -
Daily News Human Brain Organoids Thrive in Mouse Brains After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
-
The Nutshell New Ovarian Cancer Vaccine Shows Promise A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
-
Daily News The Second March for Science a Smaller Affair Many cities around the globe, including Washington, DC, saw shrunken crowd sizes, and numerous events turned into rallies rather than processions.
Current Issue
© 1986-2018 The Scientist
